Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.

Subscribe Now!

Related Content

Why Specialty Drugs Dominate Spending, and the Frontline Roles Shaping Patient Access

ByNicholas Saraceno, Editor

December 16th 2025

The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection

ByChris Dowd, ConnectiveRx

December 12th 2025

Americans Call on Policymakers to Prioritize Healthcare Access and Affordability

ByAmy Niles, PAN Foundation

December 11th 2025

Trade & Channel Strategies 2025: Channel Strategies Evolve, With Industry Leaders Pushing Toward Faster, More Connected Patient Access

ByNicholas Saraceno, Editor

December 10th 2025

HTI-4 Standards Target Lack of Transparency in Medication Access

ByNicholas Saraceno, Editor,Colin Banas, MD

December 9th 2025

2020 Patient Support Vendor Directory

Articles in this issue

Newsletter

Related Content

Why Specialty Drugs Dominate Spending, and the Frontline Roles Shaping Patient Access

The ROI Moment Pharma Keeps Missing: Point-of-Care as Revenue Protection

Americans Call on Policymakers to Prioritize Healthcare Access and Affordability

Trade & Channel Strategies 2025: Channel Strategies Evolve, With Industry Leaders Pushing Toward Faster, More Connected Patient Access

HTI-4 Standards Target Lack of Transparency in Medication Access

Trending on Pharmaceutical Commerce

Novartis’ $23 Billion Manufacturing Investment Anchors Industry Shift Toward US Onshoring

The Key to Connecting with Patients: Pharma's Market Access Transformation

Why Specialty Drugs Dominate Spending, and the Frontline Roles Shaping Patient Access

The Next Era of Drug Safety is in Intelligent Action

How AI Control Towers and Digital Twins Can Restore Pharmaceutical Profit Margins